ARN News

Originally published in Biosimilar Development by Anna Rose Welch, Editor It never ceases to excite me when I hear that some organization, hospital, or clinic

Originally published in Biosimilar Development by Anna Rose Welch, Editor Generally speaking, when it comes to fixing or advancing the U.S. healthcare system, it’s easier

TSI Healthcare, the national leader in the sales and support of customized rheumatology specific solutions, hosted its inaugural Rheumatology User Group Meeting August 2-3, 2019

Originally published in The Center for Biosimilars Biosimilars have struggled to gain ground in the United States, with few products launched, relatively low uptake of

By Colin C. Edgerton, M.D. Biosimilar Adoption Falters Rheumatologists hoped that biosimilars would reduce the costs of treating diseases such as rheumatoid arthritis (RA), and

The field of rheumatology is experiencing a workforce shortage that is expected to worsen in years to come, and many patients living with rheumatic disease

Originally published in PR Web TSI Healthcare, a national leader in the sales and support for NextGen Practice Management (PM) and Electronic Health Records (EHR)

Originally published in Veterans Health Today Colin C. Edgerton, MD, rheumatologist at Articularis Healthcare in South Carolina and chair of the American College of Rheumatology’s

ARN’s CEO Ray Waldrup is looking forward to exhibiting at the NICA conference in a couple of weeks! Stop by Booth 52 for more information

Originally published in March edition of News On Rheumatology Matters (NORM) The healthcare industry has been trying to shift away from the fee-for-service models that